ranibizumab biosimilar
/ PlantForm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 01, 2020
UPFRONT: Anti-VEGF for DR in the Real World
(Retin Physician)
- "The Early Treatment Diabetic Retinopathy Study (ETDRS) and resulting Diabetic Retinopathy Severity Scale (DRSS) were landmark National Eye Institute initiatives. The investigators classified diabetic retinopathy (DR) into 13 clinical levels based on clinical findings including hemorrhages, microaneurysms, venous beading, intraretinal microvascular abnormalities (IRMA), and neovascularization. The beauty of the scale is it allowed a physician to predict the risk of developing proliferative DR (PDR) from any given level over time. A 2-level change in the DRSS has been used by the FDA to determine whether a treatment is making a meaningful change."
Online posting
1 to 1
Of
1
Go to page
1